Clinical Research Group, Klus Apotheke Zurich, Zurich, Switzerland.
Faculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada.
Eur Radiol Exp. 2023 Apr 24;7(1):21. doi: 10.1186/s41747-023-00331-2.
We compared T1- and T2-weighted signal intensities of liver-specific (gadoxetate, gadobenate) and non-specific (gadoterate) gadolinium contrast agents (CAs) in a bile phantom.
In a phantom study, gadoxetate, gadobenate, and gadoterate were diluted in saline, blood, and bile at different concentrations (0, 0.25, 0.5. 1, 2.5, 5, 10, and 25 mM) and imaged in a 3-T magnetic resonance imaging (MRI) system using T1- and T2-weighted sequences. The maximum signal intensities of CAs were compared for each sequence separately and across all T1-weighted sequences using one-way ANOVA.
Using T1-weighted sequences, CA concentration-dependent signal intensity increase was followed by decrease due to T2* effects. Comparing CAs for each sequence in bile yielded higher maximum signal intensities with gadobenate than gadoxetate and gadoterate using T1-weighted spin-echo (p < 0.010), multiecho gradient- and spin-echo (p < 0.001), and T1-weighted high-resolution isotropic volume excitation (eTHRIVE) sequences (p < 0.010). Comparing across all T1-weighted sequences in the bile phantom, gadobenate imaged using T1-weighted turbo field-echo (TFE) sequence showed the highest signal intensity, significantly higher than that using other CAs agents or sequences (p < 0.004) except for gadobenate and gadoxetate evaluated with three-dimensional multiecho fast field-echo (3D-mFFE) and gadoxetate with T1-weighted TFE sequence (p > 0.141). Signal reduction with CA concentration-dependent decrease was observed on T2-weighted images.
In this bile phantom study of gadolinium-based CA, gadobenate and gadoxetate showed high signal intensity with T1-weighted TFE and 3D-mFFE sequences, which supports their potential utility for contrast-enhanced hepatobiliary MRI.
• Contrast-enhanced magnetic resonance (MR) cholangiography depends on contrast agent type, kinetics, and concentration in bile, • We compared signal intensities of three contrast agents in a bile phantom study. • Gadobenate, gadoxetate, and gadoterate demonstrated different signal intensities at identical concentrations. • Gadoxetate and gadobenate showed high signal intensities on T1-weighted MR sequences.
我们比较了肝特异性(钆塞酸,钆贝酸)和非特异性(钆特酸)钆对比剂(CA)在胆汁模型中的 T1 和 T2 加权信号强度。
在一项模型研究中,将钆塞酸、钆贝酸和钆特酸分别在盐水、血液和胆汁中稀释至不同浓度(0、0.25、0.5、1、2.5、5、10 和 25 mM),并在 3-T 磁共振成像(MRI)系统中使用 T1 和 T2 加权序列进行成像。分别比较了每个序列的 CA 最大信号强度,并使用单向方差分析比较了所有 T1 加权序列的信号强度。
使用 T1 加权序列,由于 T2*效应,CA 浓度依赖性信号强度增加后会下降。在胆汁中比较每个序列的 CA,使用 T1 加权自旋回波(SE)序列,钆贝酸的最大信号强度高于钆塞酸和钆特酸(p<0.010),多回波梯度和自旋回波(p<0.001),以及 T1 加权高分辨率各向同性容积激发(eTHRIVE)序列(p<0.010)。在胆汁模型中比较所有 T1 加权序列,使用 T1 加权涡轮场回波(TFE)序列成像的钆贝酸显示出最高的信号强度,明显高于其他 CA 制剂或序列(p<0.004),除了钆贝酸和钆塞酸使用三维多回波快速场回波(3D-mFFE)评估(p>0.141)和钆塞酸使用 T1 加权 TFE 序列(p>0.141)。在 T2 加权图像上观察到 CA 浓度依赖性降低导致的信号减少。
在这项关于基于钆的 CA 的胆汁模型研究中,钆贝酸和钆塞酸在 T1 加权 TFE 和 3D-mFFE 序列中显示出高信号强度,这支持它们在对比增强肝胆磁共振成像中的潜在应用。
对比增强磁共振(MR)胆管成像取决于胆汁中的对比剂类型、动力学和浓度。
我们在一项胆汁模型研究中比较了三种对比剂的信号强度。
钆贝酸、钆塞酸和钆特酸在相同浓度下显示出不同的信号强度。
钆塞酸和钆贝酸在 T1 加权磁共振序列上显示出高信号强度。